News + Filings Transactions
|
Valle Franco
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2023 | Biomea Fusion, Inc. | | Grant | Common Stock | 4.3k | $3.78 | $16.2k | | 05/31/2023 |
| 01/06/2023 | Biomea Fusion, Inc. | | Grant | Stock Option (Right to Buy) | 126.3k | $7.05 | $890.4k | | 01/06/2023 |
| 11/30/2022 | Biomea Fusion, Inc. | | Grant | Common Stock | 2.5k | $3.78 | $9.5k | | 11/30/2022 |
| 11/11/2022 | Biomea Fusion, Inc. | | Purchase | Common Stock | 4.1k | $7.63 | $31.3k | | 11/11/2022 |
| 05/31/2022 | Biomea Fusion, Inc. | | Grant | Common Stock | 3.3k | $4.67 | $15.4k | | 05/31/2022 |
| 01/14/2022 | Biomea Fusion, Inc. | | Purchase | Common Stock | 10k | $8.68 | $86.8k | | 01/14/2022 |
| 12/04/2021 | Biomea Fusion, Inc. | | Grant | Stock Option (Right to Buy) | 144.8k | $9.80 | $1.4M | | 12/04/2021 |
| 08/03/2021 | Biomea Fusion, Inc. | | Grant | Stock Option (Right to Buy) | 165k | $13.45 | $2.2M | | 08/03/2021 |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Disposition | Stock Option (Right to Buy) | 24.4k | $7.24 | $176.3k | | 01/26/2021 |
| 01/12/2021 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 1.7k | $125.45 | $219.2k | | 01/11/2021 |
| 01/12/2021 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (Right to Buy) | 1.7k | $7.24 | $12.6k | | 01/11/2021 |
| 01/11/2021 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (Right to Buy) | 1.5k | $7.24 | $10.9k | | 01/11/2021 |
| 01/11/2021 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 1.5k | $125.61 | $188.4k | | 01/11/2021 |
| 11/09/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 1.6k | $74.93 | $121.6k | | 11/09/2020 |
| 11/09/2020 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (Right to Buy) | 1.6k | $7.24 | $11.8k | | 11/09/2020 |
| 10/08/2020 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (Right to Buy) | 5.2k | $7.24 | $37.6k | | 10/07/2020 |
| 10/08/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 5.2k | $74.85 | $389.2k | | 10/07/2020 |
| 10/07/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 5.4k | $75.08 | $408.7k | | 10/07/2020 |
| 10/07/2020 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (Right to Buy) | 5k | $7.24 | $36.2k | | 10/07/2020 |
| 05/31/2020 | Eidos Therapeutics, Inc. | EIDX | Grant | Common Stock | 444 | $41.57 | $18.5k | | 05/31/2020 |
| 04/20/2020 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 2k | $7.24 | $14.5k | | 04/20/2020 |
| 04/20/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 2k | $49.79 | $99.6k | | 04/20/2020 |
| 03/26/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 3k | $47.87 | $143.6k | | 03/26/2020 |
| 03/26/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 2k | $48.85 | $97.7k | | 03/26/2020 |
| 03/26/2020 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 5k | $7.24 | $36.2k | | 03/26/2020 |
| 03/02/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 2k | $51.96 | $103.9k | | 03/02/2020 |
| 03/02/2020 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 1000 | $53.06 | $53.1k | | 03/02/2020 |
| 03/02/2020 | Eidos Therapeutics, Inc. | EIDX | Exercise | Stock Option (right to buy) | 3k | $7.24 | $21.7k | | 03/02/2020 |
|